{"disease":{"id":"pressure-ulcers-stage-iii","name":"pressure ulcers stage iii"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07391748","title":"Efficacy of a Polyhexanide Biguanide-Based Gel in the Prevention of Biofilm Formation in Pressure Ulcers","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana","has_results":false},{"nct_id":"NCT03038490","title":"The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Our Lady of Maryknoll Hospital","has_results":false},{"nct_id":"NCT03283787","title":"Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytal™ to Standard of Care in Stage 3 or 4 Pressure Injuries","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Integra LifeSciences Corporation","has_results":true},{"nct_id":"NCT05649332","title":"Study to Evaluate the Performance and Safety of the Medical Device Argogen","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Signorini Medicale S.r.l.","has_results":false},{"nct_id":"NCT05130814","title":"EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Emoled","has_results":true},{"nct_id":"NCT04311229","title":"Effectiveness of Negative-Pressure Wound Therapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Istanbul Medipol University Hospital","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}